March 17, 2023
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
January 19, 2023
UNC Lineberger's Ian Davis, MD, PhD, was awarded $1 million by the The V Foundation to support his work to improve CAR-T therapy for pediatric solid tumors.
January 9, 2023
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
January 5, 2023
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
December 9, 2022
Charles Perou, PhD, presented the 2022 AACR Distinguished Lectureship in Breast Cancer Research at the 45th San Antonio Breast Cancer Symposium.
November 18, 2022
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
November 14, 2022
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
August 24, 2022
Aziz Sancar, MD, PhD, and colleagues report that a common molecular tool for DNA labeling also has anticancer properties worthy of further investigation, especially for brain cancers.
August 24, 2022
July 22, 2022
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
